Skip to content

Clinical study of artistry hyaluronic acid vitamin C double effect serum and nutrilite collagen peptide drink to improve skin condition

Clinical study of artistry hyaluronic acid vitamin C double effect serum and nutrilite collagen peptide drink to improve skin condition

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050348
Enrollment
Unknown
Registered
2021-08-26
Start date
2021-08-23
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Improvement

Interventions

Group 1:Apply artistry hyaluronic acid C double effect serum (VC) on your face
Group 2:Oral nutrilite collagen peptide drink (SP)
Group 3:Apply artistry hyaluronic acid C double effect serum (VC) on face, and take nutrilite collagen peptide drink (SP) orally

Sponsors

Amway (China) R&D Center Co., LTD
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Subject is healthy during the test; 2.Subject is Chinese female aged 30 to 65 years; 3.Subject is willing to follow directions as outlined in the protocol to participate in all test evaluations; 4.The moisture value of skin measured by Corneometer is less than 60; 5.According to the skin aging Atlas volume 2 -Asian type grading score on crows feet>=2; 6.Take sun protection measures daily and have the habit of using sunscreen; 7.Have fully informed and signed an Informed Consent Form (ICF) before participating in this clinical test; 8.Subject agrees to maintain their habitual beauty regime during the course of the study and without any change.

Exclusion criteria

Exclusion criteria: 1.Female subject who is pregnant, nursing or planning a pregnancy; 2.Subject is currently in the active stage of skin diseases, with skin infections (bacterial, fungal and other infections); 3.The current diagnosis has a history of liver, kidney, heart, lung, digestion, blood, nerve, motor, malignant or mental diseases, which in the opinion of the principal investigator may interfere with the safety of the subject or the validity of the research results; 4.Subject used products with anti-aging and whitening claims during the study. 5.Subject is known to be highly sensitive or allergic to personal care products of the same test category. 6.Participated in other clinical studies of cosmetics, health products, medicines, etc. at present or within the last 3 months; 7.The skin condition of the test area is considered unsuitable to join the study by the principal investigator; 8.Subject has received hormone therapy at present or within the last 3 months; 9.Subject has taken oral contraceptives at present or within the last 3 months; 10.Subject has received medical cosmetic surgery or skin treatment at present or within the last 3 months; 11.Subject has taken antibiotics or antihistamines orally or externally within 1 month.

Design outcomes

Primary

MeasureTime frame
Skin moisturizing;Skin elasticity;Skin color and complexion homogeneity;

Secondary

MeasureTime frame
Skin smoothness;Skin permeability;Skin wrinkles/fine lines;Advanced glycation end products;Skin roughness;

Countries

China

Contacts

Public ContactOuyang Tianxiang

Shanghai Nutrition Society

Sarah.wang@amway.com+86 21 23056973

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026